The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Past HBV Viral Load as Predictor of Mortality and Morbidity from HCC and Chronic Liver Disease in a Prospective Study
Abstract
BACKGROUND AND AIMS: In a prospective cohort study with 11 yr of follow-up, we assessed the relationship between past hepatitis B virus (HBV) viral load and mortality. Surviving cohort members were evaluated for current liver disease. METHODS: We measured HBV viral load by real-time polymerase chain reaction on stored samples from cohort entry (1992-1993) in 2,763 hepatitis B surface antigen (HBsAg)-positive adults. Major end points were death from hepatocellular carcinoma (HCC) or chronic liver disease (CLD). There were 447 deaths. In the 1,683 survivors, we assessed severity of liver disease on a return visit in 2003. Viral load was divided into three categories: undetected (<1.6 x 10(3) copies/mL); low titer (<10(5) copies/mL); and high titer (> or =10(5) copies/mL). RESULTS: For HCC, there was a significant increase in mortality across viral load categories (p(trend) < 0.001). Compared to the HBV undetected category, the relative risk (RR) for HCC mortality in the low viral load group was 1.7 (95% confidence interval [CI] 0.5-5.7) and 11.2 (3.6-35.0) in the high viral load group. For CLD mortality, the RRs were 1.5 (0.2-12.1) and 15.2 (2.1-109.8), respectively (p(trend) < 0.001). The RR associated with high viral load did not change with increased follow-up time. In surviving cohort members evaluated for liver disease in 2003, there was also a significant association of viral load with disease severity. CONCLUSION: In this prospective study, viral load is associated with increased mortality from HCC and CLD in HBV-infected subjects. Viral load may be a useful prognostic tool in HBV infection, and interventions aimed at its reduction should be explored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wai, C.-T., Greenson, J. K., Fontana, R. J., Kalbfleisch, J. D., Marrero, J. A., Conjeevaram, H. S., & Lok, A. S.-F. (2003) · Hepatology · doi:10.1053/jhep.2003.50346 · Cited by 4,406
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
Iloeje, U. H., Yang, H., Su, J., Jen, C., You, S., & Chen, C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.016 · Cited by 1,528
Self-citationShepard, T. H. (1981) · Teratology · doi:10.1002/tera.1420230118 · Cited by 1,296
Hepatitis B virus.The major etiology of hepatocellular carcinoma
Beasley, R. P. (1988) · Cancer · doi:10.1002/1097-0142(19880515)61:10<1942::aid-cncr2820611003>3.0.co;2-j · Cited by 1,280
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,265
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Lu, S.-N., Liaw, Y.-F., You, S.-L., Sun, C.-A., Wang, L.-Y., Hsiao, C. K., Chen, P.-J., Chen, D.-S., & Chen, C.-J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013215 · Cited by 1,222
Global Epidemiology of Hepatitis B Virus
Custer, B., Sullivan, S. D., Hazlet, T. K., Iloeje, U., Veenstra, D. L., & Kowdley, K. V. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200411003-00008 · Cited by 599
Self-citationHepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
Yu, M.-W., Yeh, S.-H., Chen, P.-J., Liaw, Y.-F., Lin, C.-L., Liu, C.-J., Shih, W.-L., Kao, J.-H., Chen, D.-S., & Chen, C.-J. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji043 · Cited by 569
Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study
Bellentani, S., Tiribelli, C., Saccoccio, G., Sodde, M., Fratti, N., De Martin, C., & Christianini, G. (1994) · Hepatology · doi:10.1002/hep.1840200611 · Cited by 517
Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus
McMahon, B. J., Holck, P., Bulkow, L., & Snowball, M. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00006 · Cited by 431
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
Yuen, M.-F., Yuan, H.-J., Wong, D. K.-H., Yuen, J. C.-H., Wong, W.-M., Chan, A. O.-O., Wong, B. C.-Y., Lai, K.-C., & Lai, C.-L. (2005) · Gut · doi:10.1136/gut.2005.065136 · Cited by 375
Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection
Chu, C.-J., Hussain, M., & Lok, A. S. F. (2002) · Hepatology · doi:10.1002/hep.1840360617 · Cited by 295
Mommeja-Marin, H., Mondou, E., Blum, R. M., & Rousseau, F. (2003) · Hepatology · doi:10.1053/jhep.2003.50208 · Cited by 275
Fattovich, G., Rugge, M., Brollo, L., Pontisso, P., Noventa, F., Guido, M., Alberti, A., & Realdi, G. (1986) · Hepatology · doi:10.1002/hep.1840060203 · Cited by 273
Poynard, T., McHutchison, J., Manns, M., Myers, R. P., & Albrecht, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50319 · Cited by 253
Evans, A. A., Chen, G., Ross, E. A., Shen, F., Lin, W., & London, W. T. (2002) · PubMed · Cited by 208
Self-citationLoeb, K. R., Jerome, K. R., Goddard, J., Huang, M.-L., Cent, A., & Corey, L. (2000) · Hepatology · doi:10.1053/jhep.2000.9878 · Cited by 161
The Maze of Treatments for Hepatitis B
Lok, A. S.-F. (2005) · New England Journal of Medicine · doi:10.1056/nejme058119 · Cited by 91
Tang, B., Kruger, W. D., Chen, G., Shen, F., Lin, W. Y., Mboup, S., London, W. T., & Evans, A. A. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10559 · Cited by 88
Self-citationDevelopment and validation of a model to diagnose cirrhosis in patients with hepatitis C
Kaul, V., Friedenberg, F. K., Braitman, L. E., Anis, U., Zaeri, N., Fazili, J., Herrine, S. K., & Rothstein, K. D. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.06040.x · Cited by 55
Scoazec, J., Bringuier, A. F., Medina, J. F., Martínez‐Ansó, E., Veissière, D., Feldmann, G., & Housset, C. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80419-9 · Cited by 52
Predicting survival in hepatitis B
Sherman, M. (2005) · Gut · doi:10.1136/gut.2005.071332 · Cited by 21
Cited by
Fattovich, G., Bortolotti, F., & Donato, F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.011 · Cited by 1,348
Hepatocellular carcinoma: a review
Balogh, J., Victor, D., Asham, E. H., Burroughs, S. G., Boktour, M., Saharia, A., Li, X., Ghobrial, M., & Monsour, H. (2016) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s61146 · Cited by 1,185
Omata, M., Lesmana, L. A., Tateishi, R., Chen, P.-J., Lin, S.-M., Yoshida, H., Kudo, M., Lee, J. M., Choi, B. I., Poon, R. T. P., et al. (2010) · Hepatology International · doi:10.1007/s12072-010-9165-7 · Cited by 1,026
Chang, T.-T., Liaw, Y.-F., Wu, S.-S., Schiff, E., Han, K.-H., Lai, C.-L., Safadi, R., Lee, S. S., Halota, W., Goodman, Z., et al. (2010) · Hepatology · doi:10.1002/hep.23785 · Cited by 972
Self-citationGlobal Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & London, W. T. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.001 · Cited by 908
Self-citation
Metadata
- Authors
- Chen, G., Lin, W., Shen, F., Iloeje, U. H., London, W. T., & Evans, A. A.
- Venue
- The American Journal of Gastroenterology
- Published
- 2006-08
- Volume
- 101
- Issue
- 8
- Pages
- 1797-1803
- ISSN
- 0002-9270 (ISSN-L)
- 1572-0241
- OpenAlex
- W2140415000
- Cited by
- 275
- References
- 24
- FWCI
- 17.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.